Henry Ji
Sachigaro, Mutungamiri uye CEO
- 25+ makore echiitiko muiyo biotechnology uye hupenyu sainzi indasitiri
- Dr. Ji vakavamba Sorrento uye vakashanda semutungamiriri kubva 2006, CEO uye Mutungamiri kubva 2012, uye Sachigaro kubvira 2017.
- Munguva yekutonga kwake kuSorrento, akagadzira uye akatungamira kukura kunoshamisa kweSorrento kuburikidza nekutora uye kubatanidzwa kunosanganisira Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Animal Health, uye Deliverysa Systems Lymphatic.
- Akashanda seSorrento's Chief Scientific Officer kubva 2008 kusvika 2012 uye seInterim CEO kubva 2011 kusvika 2012.
- Asati asvika Sorrento, akabata zvinzvimbo zvepamusoro kuCombiMatrix, Stratagene uye zvakare akavamba Stratagene Genomics, mubatsiri weStratagene, uye akashanda seMutungamiri & CEO uye Director weBhodi.
- BS uye Ph.D.
Close >
Mike Royal
Chief Medical Officer
- Dr. Royal inyanzvi yemishonga ine makore makumi maviri ekukura kwekliniki uye nyaya dzezvokurapa. Nguva pfupi yadarika, aive Chief Medical Officer weSuzhou Connect Biopharmaceuticals uye, zvisati zvaitika, Concentric Analgesics. Anojoinha kuSorrento kwaaimbove EVP, Clinical Development uye Regulatory Affairs muna 20.
- Akaita basa kana kubatsira mune akati wandei akabudirira NDAs, kusanganisira maNCE, 505 (b) (2) s uye ANDAs.
- Dr. Royal ibhodhi rinopupurirwa mumishonga yemukati, mushonga wemarwadzo, anesthesiology ine zvimwe zvidzidzo mukugadzirisa marwadzo, mishonga yemishonga uye mishonga yepamutemo.
- Anga ari Mubatsiri Purofesa weMishonga paUniformed Services University of Health Sayenzi, Mubatsiri Purofesa weAnesthesiology/Critical Care Medicine paYunivhesiti yePittsburgh Medical Center, uye Adjunct Purofesa paYunivhesiti yeOklahoma uye University of California San Diego.
- Akadhinda zvakanyanya nezvitsauko zvemabhuku e190, zvinyorwa zvakaongororwa nevezera uye zvinyorwa / mapepa; uye anga ari mutauri akakokwa pamisangano yenyika nekunze
- BS, MD, JD, MBA
Close >
Elizabeth Czerepak
Executive Vice President, Chief Financial Officer, Chief Business Officer
- 35+ makore emari uye ruzivo rwekushanda mubiotech nemishonga
- Ms. Czerepak vakapedza makore 18 vari muPharma hombe uye 11 seCFO yezvigadzirwa zvakasiyana-siyana zvebiotech, kwavaitungamirira mari, kudyidzana uye kuedza kweM&A. Akatanga basa rake kuMerck & Co., akaita basa rakakosha mukutora kwaRoche $5.4B yeSyntex, uye akatungamira kuedza kwekudyidzana kweHumira® izvo zvakazoguma nekutengesa kweBASF Pharma $6.8B kuAbbott.
- Kwemakore mapfumbamwe seManaging Director kuJP Morgan uye Bear Stearns, akange achitanga mumwe wake mukuru we $212M venture fund, kwaakatungamira mainvestimenti mumabiotechs gumi nematatu, kushanda pamabhodhi uye kufambisa kubuda kuburikidza neIPO nekutora. Series 13 uye Series 7 FINRA (NASD) Registered Representative kubva 63 kusvika 2001.
- Nhengo yebhodhi ine ruzivo (inosanganisira Sorrento naScilex) uye sachigaro wekuongorora, vachiwana Corporate Director Sitifiketi kubva kuHarvard Business School muna 2020.
- BA uye MBA
Close >
Mark R. Brunswick
Mutevedzeri weMutungamiri Mukuru anoona nezvemitemo
- Dr. Brunswick vane makore anopfuura makumi matatu nemashanu ezvinzvimbo zvepamusoro muIndasitiri Yakadzorwa kusanganisira anopfuura makore mapfumbamwe muUS FDA, Center for Biologics, Division of Monoclonal Antibodies.
- Asati ajoinha Sorrento, Dr. Brunswick vaive Musoro weRegulatory Affairs and Quality paSophiris Bio, kambani inogadzira mushonga webenign prostatic hyperplasia nekenza yeprostate. Izvi zvisati zvaitika aive mukuru weRegulatory Affairs kuArena Pharmaceuticals ainyanya kurapa kwakanangidzirwa kuG Protein receptors.
- Dr. Brunswick akatungamirira boka rekutonga paElan Pharmaceuticals rinotarisa paAlzheimer Disease uye marwadzo emusanganiswa, ziconotide.
- BS uye Ph.D.
Close >
Robert D. Allen
Mutevedzeri weMutungamiri Mukuru R&D
- Dr. Allen apedza makore anopfuura gumi nemashanu ari muindasitiri yebiotechnology achitungamira tsvagiridzo, budiriro yepamberi, uye kugadzirwa kwekiriniki kwekutanga kwemishonga inorwisa mavhairasi uye inorwisa kenza.
- Vasati vajoinha Sorrento, Dr. Allen vakashanda saSainzi Director weOregon Translational Research and Development Institute (OTRADI), vachibatsirana neindasitiri uye vadyidzani vakadzidza pakutsvaga zvinodhaka uye mishandirapamwe yekunyoresa vamiriri yakanangana nekenza yehematologic, mapundu akasimba, uye hutachiona hwehutachiona.
- OTRADI isati yasvika, Dr. Allen vakagadzira zvirongwa zvekuwanikwa paSIGA Technologies izvo zvakaratidza zvakananga-anoshanda antiviral akanangana nemavhairasi mumhuri dzebunyavirus uye filovirus pamwe neanotungamirwa-anonangidzirwa matanho ekupikisa huwandu hwakawanda hwehutachiona hwevanhu uye inosungira intracellular bacteria.
- BS uye Ph.D.
Close >
Xiao Xu
Mutungamiri ACEA
- Dr. Xu vane makore anopfuura makumi maviri echiitiko semukuru mumaindasitiri ebiotech. Dr. Xu aive cofounder, mutungamiri uye CEO weACEA Biosciences (yakawanikwa neAgilent muna 20) uye ACEA Therapeutics (yakawanikwa ne Sorrento Therapeutics muna 2021). Anobatana Sorrento Therapeutics mushure mekutora, uye anoenderera mberi achishanda seMutungamiriri weACEA, mubatsiri we Sorrento Therapeutics.
- Anga achitonga uye achitarisira ACEA yekuvandudza mushonga pombi yekuvandudza, zvidzidzo zvekiriniki, uye cGMP kugadzira nzvimbo.
- Aive muvambi weiyo innovative label yemahara cell-based assay tekinoroji uye ane mutoro wehunyanzvi / kusimudzira chigadzirwa uye kudyidzana kwebhizinesi neRoche Diagnosis, kushambadzira kwepasirese kweACEA's proprietary tekinoroji uye zvigadzirwa, uye $250 miriyoni Agilent kutora kweACEA Biosciences.
- Anga ari muongorori wevashandi uye sainzi wekutsvagisa kuGladstone Institutes, The Scripps Research Institute uye US Centers for Disease Control and Prevention. Ane anopfuura makumi mashanu eUS patents uye patent application uye akaburitsa zvinopfuura makumi matanhatu zvinyorwa zvekutsvagisa mumajenari epasi rese, anosanganisira Sainzi, PNAS, Nature Biotechnology, uye Chemistry neBiology.
- BS, MS, uye MD
Close >
Shawn Sahebi
Mutevedzeri weMutungamiri Mukuru weCommerce Operations
- Dr. Sahebi anotungamira Sorrento's commercial operations function
- Inounza anopfuura makore makumi matatu eruzivo rwemishonga kusanganisira yekushambadzira sainzi uye bhizinesi zano kuSorrento
- Asati ajoinha Sorrento, akabata zvinzvimbo zvepamusoro naNovartis, Pfizer, naLilly vachigadzira analytics yekutengeserana uye nzira dzekushambadzira dzinofambiswa nedhata dzakakonzeresa kukura kwekutengesa kwezvinhu zvinopfuura makumi maviri zvinosvika blockbuster chinzvimbo munzvimbo dzeCardiovascular, Arthritis, Neuroscience, Diabetes, uye Oncology.
- Mutendi akasimba kuti tsika dzekubatana dzinogadzira zvikwata zvinokunda
- Mutungamiri Akapfuura, Pharmaceutical Management Science Association yeAmerica
- BA, MBA uye Ph.D.
Close >
Brian Cooley
Mutevedzeri Mukuru weMutungamiri, Corporate Communications uye Lymphatic Drug Development BU
- 30+ makore echiitiko muiyo biopharmaceutical uye hupenyu sainzi indasitiri
- VaCooley vakabata zvinzvimbo zvakasiyana-siyana zvekutengesa, kushambadzira, uye hutungamiriri hwekutengeserana kumakambani ane rombo rakanaka 500 uye vakatungamira kubudirira kuunganidza mari nekutanga kuedza kumakambani ehunyanzvi hwekuchengetedza hutano.
- Vasati vajoinha Sorrento, Mr. Cooley vakatungamira kushambadzira kwepasi rose kuedza kwekutanga chigadzirwa nebasa reP&L paEli Lilly neCompany neGenentech munzvimbo dzechirwere dzinosanganisira Diabetes, Neurology, Immunology uye Rare Disease.
- Pamusoro pezvo, akatungamirawo zvakakosha BD, mu-rezinesi, uye kuedza kwekubatanidza pasi rose uye muUS Izvi zvaisanganisira akawanda mabhizinesi ekuwedzera madhiri kuEurope, Middle East neAfrica, uye chibvumirano chekubatana chemadhora mazana mana eMM ku-rezenisi, kusimudzira nekutengesa. yekutanga GLP-400 agonist
- Munguva pfupi yapfuura, Mr. Cooley vaiva CBO yeSofusa Business Unit paKimberly-Clark uye vakatungamirira kubudirira kwekutengesa nekubatanidza kuedza. Sorrento Therapeutics. Anoenderera mberi achitungamira chikamu cheLymphatic Drug Delivery system kuSorrento.
- BS
Close >
Bill Farley
Mutevedzeri weMutungamiriri weBusiness Development
- 30+ makore echiitiko muBusiness Development, Kutengesa uye kutungamira kuedza mukutsvaga zvinodhaka, kusimudzira uye kudyidzana
- Asati ajoinha Sorrento, VaFarley vakabata zvinzvimbo zvehutungamiriri kuHitGen, WuXi Apptec, VP weChii Accounts kuvaka uye kutungamirira boka repasi rose reBD; ChemDiv, VP weBD pa, achitungamira kuedza kwakawanda kugadzira makambani matsva ekurapa muCNS, Oncology uye Anti-infectives.
- VaFarley vakashanda sechipangamazano kuzvikwata zvakasiyana-siyana zvekutungamira manejimendi uye maBOD kuti vagadzire nekutengesa midziyo yakafanana neXencor, Caliper Technologies neStratagene.
- Akavaka network yakasimba mumakambani emishonga, biotech uye Venture Capital nharaunda. VaFarley vataura pamisangano yakawanda uye vakadhindwa muzvinyorwa zvakasiyana-siyana zvakaongororwa nevezera ravo
- BS
Close >
Alexis Nahama
Mutevedzeri Mukuru weMutungamiri Neurotherapeutics BU
- Dr. Nahama vanotungamira zvirongwa zveRTX zveutano hwevanhu nemhuka
- Sechikwata chehutungamiriri hwenhengo, Dr. Nahama vanotsigira kuvandudzwa kwehurongwa, vanotarisira mapurojekiti akanyanya kukosha, vanofambisa kuenda kugadziriro yemusika, uye vanosimudzira kuedza kwemubatanidzwa wekunze.
- Neshungu inotyaira mikana yeshanduro yekumhanyisa zvirongwa zvekusimudzira vanhu uku uchiunza matekinoroji angadai asiri kuwanikwa kumhuka dzinovaraidza.
- Asati ajoina Sorrento, akapedza makore anopfuura makumi maviri nemashanu akabata mabasa epamusoro pasi rose achishanda muLife Sayenzi neBiotechnology yeSanofi, Colgate, Novartis, Merck, VCA Antech uye VetStem Biopharma.
- DVM ine basa rekutanga rakanangana neR&D munzvimbo yekurwadziwa (miyedzo yekiriniki yezvipfuyo)
Close >